The News
Portfolio Companies in the News
» 23/12/04
CropDesign appoints new CEO
» 16/12/04
Esmertec to further secure mobile Java content with SATSA-based implementation from Gemplus
» 16/12/04
Diatos moves its lead drug, DTS-201, toward clinical trials in Europe
» 09/12/04
Esmertec to Integrate Hybrid’s OpenGL ES based Graphics Solutions into its Jbed Solution
» 06/12/04
Phase I/II Experience of Pixantrone CHOP-Variant (CPOP)
» 05/12/04
TRISENOX® Produces Hematologic Responses in 30 Percent of Patients with Higher-Risk MDS
» 23/11/04
Sendo has chosen Esmertec’s Java solution for its mobile phones
» 22/11/04
Ablynx appoints Edwin Moses as chairman of the board of directors
» 18/11/04
Esmertec Establishes Strategic Relationship with Mitsui & Co.
» 10/11/04
Varioptic Selected Most Innovative Company of the Year for Its Liquid Lenses
» 26/10/04
Intransa annouces IP5500 - The industry's next-generation modular IP san solution for the mid-market
» 26/10/04
Esmertec raises CHF 23.5 Million from convertible note to fund growth
» 23/09/04
France Telecom selects Esmertec as technology partner for its embedded Java platforms
» 20/09/04
Cellzome AG Announces Partnership Agreement with Novartis
» 14/09/04
Dr. Ulrich Schumacher joins Esmertec as a Member of the Board of Directors
» 08/09/04
Oxxius receives 2.4 million euros from Sofinnova Partners in first round of financing
» 06/09/04
Sensitive Object secures 2 million € Series A financing round from Sofinnova Partners
» 30/08/04
Tony Reis, Former CEO of Swisscom, joins Esmertec’s Board of Directors
» 24/08/04
Enfora partners with Esmertec to enable wireless Java technology in their GSM/GPRS OEM devices
» 16/08/04
Intransa secures twenty five million dollars in series D funding
» 02/08/04
Highest Java™ Performance Achieved by the MIPS32® 24Kc™ Core
» 30/07/04
6WIND emporers customers and partners with a further commitment to quality
» 28/07/04
Diatos Elected Among the Top 15 Emerging Biotech Companies of 2004
» 27/07/04
Esmertec acquires OOVM
» 26/07/04
Cell Therapeutics, Inc. Completes Enrollment in Third Pivotal Trial of XYOTAX™ in Lung Cancer
» 22/07/04
Esmertec welcomes Michel Bon, Former CEO and Chairman of France Telecom, to its Board
» 19/07/04
Ablynx and Procter&Gamble form nanobody drug discovery and development partnership
» 12/07/04
Qosmos receives a first round of financing from Sofinnova Partners
» 07/07/04
Esmertec is opening Customer Support and Testing Centre in Taipei, Taiwan
» 06/07/04
Atomz Named to Second-Annual AlwaysOnTM List of Top 100 Private Companies
» 30/06/04
NIF Ventures acquires a stake in Varioptic S.A.
» 28/06/04
Esmertec’s Java™ Virtual Machine (JVM) solution for mobile phones is selected by Panasonic
» 22/06/04
Esmertec to demonstrate new breakthrough Java™ Solution – Jbed™ Advanced during JavaOne 2004
» 14/06/04
TRISENOX® Produces Hematologic Responses in 27 Percent of MDS Patients
» 17/05/04
Addex Pharmaceuticals Completes Largest ever European Biotech Series B Fund Raising
» 12/05/04
Ingenium Acquires Pivotal Patents for INGENOtypingTM Platform
» 10/05/04
Faust raises 16 million euros to further develop its product candidates
» 05/05/04
Georges Haas, Ph.D., Joins Ingenium’s Supervisory Board Munich, Germany, May 5, 2004
» 03/05/04
Saegis Pharmaceuticals Begins Phase II Clinical Trial of SGS742 for Alzheimer’s Disease
» 03/05/04
Vidiom Systems Selects Esmertec™ to provide the JVM solution for its OCAP Products
» 27/04/04
Actelion announces first quarter results 2004
» 20/04/04
Cell Therapeutics Initiates Phase I/II Study of CT-2106
» 07/04/04
Esmertec™ provides Time Warner Cable with JVM solution for the OCAP Market
» 06/04/04
Ablynx closes €25 million Series B Financing
» 26/02/04
Esmertec gains a worldwide leadership role in fast growing mobile Java™ markets
» 25/02/04
Gruenenthal and Ingenium Enter INGENOtyping™ Agreement
» 25/02/04
Diatos S.A. Closes Euro 7 Million in a New Financing Round
» 24/02/04
MARCONI and CTS announce partnership agreement
» 16/02/04
Cobion acquired by Internet Security Systems
Sofinnova in the News
» 23/02/04
SOFINNOVA earmarks €85 million to accelerate activity in European wireless market
Events
» 16/08/04
Jean Schmitt dans Microméga/RFI
» 09/08/04
"Euronext n'a pas la place financière qu'il mérite" Jean-Bernard Schmidt - Les Echos 9 Août 2004 -
» 21/01/04
Opération Tremplin Entreprise 2004